---
title: "Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences Conference"
datePublished: Thu Mar 04 2021 11:23:54 GMT+0000 (Coordinated Universal Time)
cuid: cm6zytxsc000009jxdj1b9b08
slug: 1384

---


바이오 제약기업 Kindred Biosciences, Inc.(나스닥 : KIN)가 3월 10일 Barclays 글로벌 헬스 케어 컨퍼런스와 3월 9-10일 HC Wainwright 글로벌 생명 과학 컨퍼런스에서 발표할 예정이다. 이 기간 동안 투자자는 최근 개발, 개발중인 주요 치료 프로그램의 연구 결과 및 향후 이정표에 대해 논의할 기회를 갖게된다.

![이미지](https://cdn.hashnode.com/res/hashnode/image/upload/v1739247122860/9bc1b854-6ac6-4935-8576-fe858c78ee0f.jpeg)

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Barclays Global Healthcare Conference on March 10 and the H.C. Wainwright Global Life Sciences Conference on March 9-10.

Dr. Richard Chin, Chief Executive Officer, will be available for one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones.

Conference Details:

Barclays Global Healthcare Conference

Date: March 10, 2021

Presentation time: 2:25 – 2.50p.m. ET, Virtual Track 3

Webcast URL: Click here

H.C. Wainwright Global Life Sciences Conference

Date: March 9-10, 2021

Presentation time: On demand access beginning March 9

Webcast URL: Click here

An archived version of the above webcasts will be available for 30 days on the KindredBio website.

- 웹사이트 : www.kindredbio.com/

관련 글

└ 바이오의약품 기업 킨드레드 바이오사이언스(Kindred Biosciences), 'BofA 증권 동물건강 가상 서밋'에서 발표 예정